Somaxon Pharmaceuticals, Inc.

(NASDAQ:SOMX)

Key Stats & Ratios

Valuation
Market Cap 31.33M
P/E
P/E (Trailing) -0.95
P/E (Forward)
Price/Sales
Price/Book 2.21
EPS -1.95
EPS Growth (ttm)
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Jun 2008
Profitability
Operating Income -36129000.00
Net Income -35578000.00
Profit Margin (ttm)
Operating Margin (ttm)
Management Effectiveness
Return on Assets (ttm) -108.80%
Return on Equity (ttm)
EBIT Margin (ttm)
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 29.55M
Revenue
Revenue/Share
Revenue Growth (ytd)
Annual Revenue Growth Rate (3Y)
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 131.00K
EBITDA -35998000.00
Diluted EPS (ttm) -1.95
Balance Sheet
Total Cash 13.64M
Total Cash/Share 0.74
Total Assets 32.69M
Total Liabilities 19.61M
Total Debt/Equity 1.00
Long Term Debt Common Equity Ratio 0.81
Current Ratio 2.00
Leverage Ratio 2.00
Book Value/Share 0.71
Cash Flow
Cash Flow -35447000.00
Free Cash Flow -21503000.00
Cash Flow/Share -1.92
Free Cash Flow/Share -1.17

Trading Information

Stock Price History
Beta
52Wk Change -62.00%
52Wk Change Vs. Mkt -41.00%
52Wk High 5.95
52Wk Low 0.98
10 Day Moving Average 1.47
200 Day Moving Average 3.38
Share Statistics
Average Volume 15.10K
Shares Outstanding 18.43M
Shares Float 17.48M
% Held by Insiders 5.20%
% Held by Institutions 39.20%
Shares Short (As of Dec 10, 2008) 325.16K
Short Ratio 21.30
Short % of Float 1.90%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount